Ocular Therapeutix Inc. (OCUL)
NASDAQ: OCUL
· Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT
Ocular Therapeutix Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 391.13M | 349.68M | 392.1M | 427.22M | 459.69M | 483.04M | 195.96M | 110.55M | 66.61M | 79.03M | 102.3M | 120.95M | 134.54M | 145.42M | 164.16M | 179.28M | 191.86M | 209.38M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.61M | n/a | n/a | n/a | n/a | 1.61M | 1.61M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M |
Other Long-Term Assets | n/a | 1.61M | 1.61M | 1.61M | 1.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 30.41M | 25.22M | 32.39M | 30.23M | 30.23M | 26.55M | 26.18M | 23.59M | 27.31M | 21.12M | 21.32M | 19.8M | 20.48M | 23.21M | 21.14M | 19.55M | 18.73M | 13.63M |
Inventory | 3.04M | 3.27M | 3.04M | 2.4M | 2.55M | 2.57M | 2.31M | 2.26M | 2.2M | 2.27M | 1.97M | 1.54M | 1.5M | 1.36M | 1.25M | 1.22M | 1.11M | 1.12M |
Other Current Assets | 8.79M | 9.52M | 13.46M | 13.15M | 6.12M | 150K | 7.94M | 4.86M | 4.59M | 4.75M | 4.03M | 3.32M | 3.8M | 4.67M | 4.75M | 3.88M | 4.82M | 4M |
Total Current Assets | 433.38M | 387.69M | 440.99M | 473.01M | 498.58M | 519.82M | 232.24M | 141.26M | 100.71M | 107.16M | 129.63M | 145.62M | 160.32M | 174.65M | 191.3M | 203.93M | 216.52M | 228.13M |
Property-Plant & Equipment | 16.34M | 16.61M | 15.33M | 15.74M | 16.89M | 17.51M | 18.21M | 19.36M | 20.08M | 19.65M | 17.9M | 11.2M | 10.98M | 11.21M | 11.82M | 12.04M | 12.42M | 13.14M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 17.96M | 18.23M | 16.95M | 17.36M | 18.51M | 19.12M | 19.82M | 21.13M | 21.85M | 21.41M | 19.66M | 12.96M | 12.75M | 12.97M | 13.59M | 13.81M | 14.18M | 14.91M |
Total Assets | 451.33M | 405.92M | 457.94M | 490.37M | 517.09M | 538.95M | 252.06M | 162.38M | 122.56M | 128.57M | 149.29M | 158.58M | 173.07M | 187.62M | 204.89M | 217.74M | 230.71M | 243.04M |
Account Payables | 5.89M | 4.63M | 4.18M | 4M | 3.69M | 6.45M | 4.39M | 3.98M | 3.57M | 5.44M | 5.12M | 5.31M | 3.7M | 3.42M | 4.59M | 4.25M | 3.88M | 4.15M |
Deferred Revenue | 14M | 64K | 128K | 190K | 269K | 263K | 255K | 317K | 391K | 463K | 576K | 603K | 1.19M | 1.21M | 13M | 12M | 12M | 12M |
Short-Term Debt | 2.63M | 2.16M | n/a | n/a | 1.66M | n/a | 1.59M | 1.88M | 3.8M | 1.82M | n/a | 1.74M | 1.77M | 1.7M | n/a | 1.55M | 1.49M | 9.71M |
Other Current Liabilities | 24.23M | 31.08M | 22.78M | n/a | 14.27M | 10.67M | 18.92M | 19.15M | 16.65M | 15.65M | 16.59M | 13.17M | 12.93M | 12.42M | 13.52M | 11.05M | 9.82M | 8.92M |
Total Current Liabilities | 42.93M | 37.93M | 41.35M | 36.36M | 29.97M | 24.3M | 34.9M | 35.07M | 32.36M | 29.71M | 31.39M | 29.27M | 26.11M | 23.96M | 26.34M | 25.16M | 21.55M | 27.44M |
Long-Term Debt | 69.91M | 74.07M | 68.5M | 67.81M | 67.13M | 66.46M | 74.92M | 73.89M | 53.28M | 54.68M | 54.01M | 53.34M | 52.7M | 52.06M | 51.44M | 50.82M | 50.24M | 39.73M |
Other Long-Term Liabilities | 14.17M | 28M | 13.39M | 28.58M | 22.19M | 19.73M | 30.09M | 24.13M | 11.89M | 13.01M | 6.44M | 11.59M | 10.46M | 13.23M | 20.19M | 36.06M | 59.9M | 73.3M |
Total Long-Term Liabilities | 102.49M | 102.06M | 101.24M | 101.99M | 109.42M | 106.67M | 126.03M | 119.47M | 87.11M | 89.15M | 82.52M | 83.08M | 81.16M | 83.87M | 90.55M | 105.24M | 128.91M | 132.19M |
Total Liabilities | 145.42M | 139.99M | 142.59M | 138.35M | 139.4M | 130.96M | 160.93M | 154.53M | 119.47M | 118.86M | 113.91M | 112.35M | 107.27M | 107.83M | 116.89M | 130.4M | 150.46M | 159.63M |
Total Debt | 76.94M | 76.22M | 75.78M | 75.12M | 74.89M | 74.41M | 83.39M | 83.02M | 64.77M | 64.61M | 64.28M | 59.7M | 59.47M | 59.23M | 58.98M | 58.73M | 58.5M | 56.61M |
Common Stock | 17K | 16K | 16K | 16K | 16K | 15K | 12K | 8K | 8K | 8K | 8K | 8K | 8K | 8K | 8K | 8K | 8K | 8K |
Retained Earnings | -1.02B | -955.14M | -891.08M | -842.7M | -806.2M | -762.43M | -697.58M | -668.36M | -667.84M | -647.16M | -616.84M | -601.3M | -577.11M | -558.35M | -545.8M | -541.95M | -544.61M | -536.13M |
Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | 0.00 | n/a | n/a | -0.00 | -0.00 | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 305.92M | 265.93M | 315.34M | 352.02M | 377.69M | 407.98M | 91.13M | 7.85M | 3.09M | 9.71M | 35.38M | 46.23M | 65.8M | 79.8M | 88M | 87.34M | 80.25M | 83.41M |
Total Investments | 1.61M | n/a | n/a | n/a | 1.61M | 1.61M | 1.61M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M | 1.76M |